Kenyan e-health company MyDawa has received $20 million in funding from private equity investor Alta Semper Capital in order to build an all-encompassing consumer health platform.
MyDawa, which made its debut as an e-pharmacy in 2016, has since grown to offer laboratory services at its expanding network of walk-in pharmacies and health centres in addition to online and in-person consultations.
In order to help other healthcare businesses grow, it has also launched its own line of branded products and plans to open up its digital infrastructure from telemedicine to fulfilment.
It has already struck contracts with some of the biggest clinic chains in Kenya with the intention of expanding their reach.
Kenyan Startup Revivo secures $635k to expand its Offerings in Emerging Markets
In addition, MyDawa has bought Uganda’s Guardian Health, one of numerous purchases and partnerships that the company plans to undertake as it extends beyond Kenya. Priscilla Muhiu, formerly of Glovo Kenya, will lead the company’s expansion efforts.
MyDawa co-founder Neil O’Leary commented on the funding and latest acquisition, saying that Alta Semper’s aim matches that of MyDawa, and it brings the drive, contacts, and clout to succeed.
Three years ago, AAIC, a Japanese-backed African healthcare fund, became the first external investor, and the team has now been strengthened to the greatest extent feasible.
“MyDawa now has a solid secure base as well as a fantastic expansion opportunity based on a fantastic offering that improves health outcomes.” “Guardian is a fantastic first step toward realising our ambition,” O’Leary added.
In 2019, MyDawa acquired a $3 million grant from AAIC’s Africa Healthcare Fund, as well as a $1.2 million grant from the Bill & Melinda Gates Foundation, to combat the spread of HIV/AIDS by improving access to PrEP (Pre-Exposure Prophylaxis) medication.
